CLOSE X

AKUMS DRUGS & PHARMACEUTICALS LTD.

NSE : AKUMSBSE : 544222ISIN CODE : INE09XN01023Industry : Pharmaceuticals & DrugsHouse : Private
BSE514.85-2.55 (-0.49 %)
PREV CLOSE ( ) 517.40
OPEN PRICE ( ) 521.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5995
TODAY'S LOW / HIGH ( )511.30 524.75
52 WK LOW / HIGH ( )407.4 1174.85
NSE513.90-5.35 (-1.03 %)
PREV CLOSE( ) 519.25
OPEN PRICE ( ) 520.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 513.90 (34)
VOLUME 263863
TODAY'S LOW / HIGH( ) 510.70 524.85
52 WK LOW / HIGH ( )405 1175.9
GO
(Rs.in Million)
Particulars
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
10555.47
10104.11
10330.87
10191.13
Total Expenditure
9616.34
8890.46
9119.02
8910.96
PBIDT (Excl OI)
939.13
1213.65
1211.85
1280.17
Other Income
175.45
145.61
134.70
65.46
Operating Profit
1114.58
1359.26
1346.55
1345.63
Interest
45.42
51.34
119.03
130.21
Exceptional Items
82.17
47.81
36.99
NA
PBDT
1151.33
1355.73
1264.51
1215.42
Depreciation
399.97
445.20
348.65
340.64
Profit Before Tax
751.36
910.53
915.86
874.78
Tax
-744.70
247.41
249.35
262.70
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
1496.06
663.12
666.51
612.08
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
1496.06
663.12
666.51
612.08
Minority Interest
-19.89
-11.30
-14.45
-10.37
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
1476.17
651.82
652.06
601.71
Equity Capital
306.21
306.21
306.21
286.13
Face Value (IN RS)
2.00
2.00
2.00
2.00
Reserves
NA
NA
NA
NA
Calculated EPS
9.64
4.26
4.26
4.21
Calculated EPS (Annualised)
38.57
17.03
17.04
16.82
No of Public Share Holdings
38938608.00
38938608.00
38938608.00
NA
% of Public Share Holdings
24.74
24.74
24.74
NA
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
8.90
12.01
11.73
12.56
PBIDTM%
10.56
13.45
13.03
13.20
PBDTM%
10.91
13.42
12.24
11.93
PBTM%
7.12
9.01
8.87
8.58
PATM%
14.17
6.56
6.45
6.01
 
Notes
Notes
Notes
Notes
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors